CHRNA7 and amyotrophic lateral sclerosis: GBH effects, directly and via melatonergic pathway suppression, will lower α7nAChR levels with possible consequences for astrocyte, microglia, vagal nerve, gut microbiome/permeability, and Schwann cell/NMJ alterations in ALS pathophysiology.